Search »
- Use quotation marks (e.g., "RSR Manual") to search for exact phrases.
- You must be logged in to search for people in the Ryan White/TargetHIV community.
Content type
Topic Areas
Source
Publication Date
-
-
Ryan White Part A-F Awards Announced for FY21
From the HRSA HIV/AIDS Bureau Update: Special Bulletin - 10/5/21
News Article updated on 10/06/2021 -
EHE Resource Recap, October 2021
HHS has funded multiple agencies to deliver technical assistance and training to Ending the HIV Epid
News Article updated on 10/18/2021 -
Rapid ART: An Essential Strategy for Ending the HIV Epidemic
What HIV care providers can do to create a rapid ART program to get HIV clients on treatment the same day as a diagnosis.Resource updated 09/19/2023
-
Rapid ART Playbook Outlines Steps to Implementation
Guide on implementing rapid ART the administration of antiretroviral therapy (ART) as quickly as possible and ideally on the same day as an HIV diagnosis/clinic visit.Blog updated 03/03/2022
-
TAP-in EHE Webinar Series
Recordings of the TAP-in webinars on topics critical to the Ending the HIV Epidemic Initiative.Resource updated 05/23/2023
-
RWHAP Eligibility Toolkit
Toolkit for HRSA RWHAP Part B and ADAP recipients to guide design of systems and processes for eligibility determination and recertification.Resource updated 09/20/2023
-
ADAP Formulary Coverage of Mental Health Treatment Fact Sheet
Tips for RWHAP AIDS Drug Assistance Programs in supporting access to mental health medications and related services.Resource updated 09/14/2023
-
Needs Assessment Tool Series: Focus Groups
-
HRSA Revises RWHAP Policy Notice on Eligibility Determinations
In October 2021, HRSA's HIV/AIDS Bureau revised its client eligibility and recertification policy for the Ryan White HIV/AIDS Program.
News Article updated on 11/02/2021 -
HRSA Releases New Fact Sheets on RWHAP Clients
Ten fact sheets on client populations getting care from the Ryan White HIV/AIDS Program (RWHAP) a
News Article updated on 06/30/2021 -
Use of Social Media and Mobile Technology as Essential Tools for EHE
Strategies to engage hard-to-reach youth and young adults through use of social media and related technologies.Resource updated 03/15/2023
-
Online Course on Integrated Planning
-
Ending the HIV Epidemic through Innovations in Rapid ART
Review of innovative Rapid ART strategies in diverse settings.Resource updated 03/15/2023
-
Innovation and Resilience: How Ryan White HIV/AIDS Program Recipients Leverage Telehealth during the COVID-19 Pandemic
Recap of changes made in telehealth laws, regulations, and policies and corresponding efforts of healthcare systems, payers, and providers to modify their services to keep clients with HIV engaged in care provided by HRSA's Ryan White HIV/AIDS Program.Resource updated 06/09/2022
-
Reflections on COVID-19 Driven Telehealth Implementation in the RWHAP
The HRSA white page Innovation and Resilience: How Ryan White HIV/AIDS Program Recipients Leverage Telehealth during the COVID-19 Pandemic offers lessons for future service delivery.Blog updated 01/23/2023
-
HIV 101: Fundamentals of HIV Pathogenesis, Antiretroviral Therapy Initiation, & Primary Care for PWH
Session for clinicians new to the field of HIV or those looking for a review on the core principles of HIV management, including pathogenesis of HIV infection, mechanism of action of antiretroviral drugs, initiating antiretroviral therapy, and primary care for people with HIV.Resource (Conference Presentation) updated 09/14/2023
-
Innovative Intervention Strategies (2iS)
HRSA SPNS project applying the implementation science framework to identify innovative HIV interventions for three priority populations (people with substance use disorder, sexual minority youth, people involved in criminal justice system) and use of telehealth. Project period: 2021-2025.RWHAP Technical Assistance Provider updated on 04/02/2024
-
Challenges and Opportunities for Telemedicine
Review of the advantages and disadvantages of telemedicine, review of regulations, and impact of telemedicine on health outcomes.Resource (Conference Presentation) updated 09/14/2023
-
New Investigational ART Drugs and Strategies
Review of investigational drugs in phase III trials (as of 2021: Islatravir, Lenacapravir, GSK 3640254/aka GSK “254) and how these investigational agents might be used in treatment in the future. Also, review of long-acting injectables.Resource (Conference Presentation) updated 09/14/2023